Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;2(1):6-10.
doi: 10.4161/chim.2.1.15151.

Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis

Affiliations

Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis

Evan M Bloch et al. Chimerism. 2011 Jan.

Abstract

Background: Fetal microchimerism (F-MC), the persistence of fetal cells in the mother, is frequently encountered following pregnancy. The high prevalence of F-MC in autoimmune disease prompts consideration of the role for immune tolerance and regulation. This study examines the association between F-MC and multiple sclerosis (MS), an autoimmune disorder, of undetermined etiology.

Results: 21 out of 51 MS-positive subjects (41%) were classified as positive for F-MC; 4 of 22 (18%) of MS-negative sibling controls, were also positive for MC (p = 0.066). Unanticipated F-MC in controls lead to re-evaluation using 30 female singleton cord blood units (CBUs) as a biological control. Four CBUs were low-level positive.

Study design and methods: Seventy-three female subjects were assigned to three groups according to disease status and pregnancy history: (1) MS positive (+) women with a history of one male pregnancy before symptom onset (n = 27); (2) MS negative (-) female siblings of MS(+) women with a history of one male pregnancy (n = 22); and (3) MS(+) women that reported never having been pregnant (n = 24). Ten micrograms of genomic DNA obtained from peripheral blood leukocytes of each subject were analyzed for F-MC using allele-specific real-time PCR targeting the SR-Y sequence on the Y-chromosome. MC classification was dichotomous (positive vs. negative) based on PCR results.

Conclusion: The association between F-MC and MS warrants further study to define this relationship. F-MC in women self-reporting as nulligravid, supports previous findings that a significant proportion of pregnancies go undetected. This lead to re-validation of a Y-chromosome based assay for F-MC detection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Amplification Curve. The assay is performed in a 96 well plate where each well is monitored at every cycle for fluorescent intensity (Rn, y-axis). As PCR progresses and generation of new amplicons, Rn increases until reaching a plateau. At the end of each run, a user-defined threshold is set. This threshold is the level of fluorescence at which CTs or threshold cycle, is calculated. This threshold is set higher than the noise level in the baseline. During the reaction, the cycle number at which the fluorescent intensity crosses the threshold value is defined as CT. The CT represents the cycle at which a statistically significant increase in ΔRn is first detected. Therefore, samples with a low CT have an abundant target. In this figure, the threshold is set to 1 and the CT of the female DNA spiked with positive DNA is at an average of 35.5. The DNA from a female subject (negative) does not cross the threshold. (B) Dissociation Curve. At the end of the cycle, the generated amplicons were analyzed for specificity. The amplified products were melted by increasing the temperature to 95°C with melt temperature corresponding to the temperature at which half of the amplicons are denatured. The derivative (y-axis) is the slope of the curve generated by the melting curve. The peak of the dissociation curve is equal to the melting temperature. Temperature is labeled on x-axis (60°C to 95°C). In this figure the spiked positive DNA melts at 83°C. The DNA from a female subject (negative) predictably failed to generate any amplified product.

Similar articles

Cited by

References

    1. Steinman L, Martin R, Bernard C, Conlon P, Oksenberg JR. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu Rev Neurosci. 2002;25:491–505. - PubMed
    1. Murray TJ. The history of multiple sclerosis: the changing frame of the disease over the centuries. J Neurol Sci. 2009;277:3–8. - PubMed
    1. Chaudhuri A, Behan PO. Multiple sclerosis is not an autoimmune disease. Arch Neurol. 2004;61:1610–1612. - PubMed
    1. Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol. 2004;61:1613–1615. - PubMed
    1. Racke MK, Lovett-Racke AE, Karandikar NJ. The mechanism of action of glatiramer acetate treatment in multiple sclerosis. Neurology. 2010;74:25–30. - PubMed